SCHOTT Pharma Unveils Next-Generation Polymer Syringe System

Source: SCHOTT Pharma

Pharmaceutical packaging company, SCHOTT Pharma, has introduced its SCHOTT TOPPAC® infuse polymer syringe system; a new cap design for prefillable polymer syringes featuring tamper evidence at the individual syringe level.

Developed in partnership with Schreiner MediPharm and Körber Pharma, the integrated label offers first-opening indication, oxygen and light protection, and optional RFID chips for traceability and inventory management. By employing carton-based secondary packaging, the new product reduces the carbon footprint of the supply chain compared to its blister-packed predecessor by up to 58%.

SCHOTT Pharma's next generation SCHOTT TOPPAC® infuse prefillable polymer syringes are designed to streamline hospital processes from pre-op to inventory by reducing manual preparation steps and minimizing medication errors.

At the heart of the new syringe system is a pre-assembled cap that simplifies the filling process for pharmaceutical companies. The next generation of SCHOTT TOPPAC® infuse syringes can be filled on existing filling lines without requiring modifications or additional investment. Combined with a functional label, the new design covers the syringe shoulder completely, providing a first-opening indication for each syringe. With conventional syringe systems, the first-opening mark can only be found on the secondary packaging. However, when provided directly at the point of use, the syringe can be re-used if it has not been previously opened. Combined with the high-quality cyclic olefin copolymer (COC) material used to manufacture SCHOTT TOPPAC® infuse, the new syringe system ensures drug stability throughout its shelf life, thus reducing the risk of drug contamination.

The new cap design allows for a functional label that provides additional protection, such as oxygen and light protection, but can also contain relevant information about the specific medication, such as expiration date or batch number. These can be digitalized by integrating them into the label with an RFID chip, enabling an automated, more efficient medication inventory process. "An RFID chip in the label reduces the preparation time of an anesthesia tray, for example, from 20 minutes to just two minutes, significantly increasing operational efficiency. Moreover, the label-integrated RFID chip enables a digital first-opening indication," explains Dr. Nadine Lampka, Senior Product Manager Pharma-Security at Schreiner MediPharm.

While traditional secondary packaging for prefilled polymer syringes consists of a polymer blister, the new cap and label features provide the basis for a blister-free package, while allowing for a first-opening indication, maintaining the integrity of the prefilled syringe and protecting against mechanical impact or dust. This allows the use of cartons instead of polymer blisters, which are easier to open for nurses and doctors, less space-consuming for disposal, and easier to recycle.

Reduced time to market

The new SCHOTT TOPPAC® infuse prefillable polymer syringe system also accelerates time-to-market for pharmaceutical companies. SCHOTT Pharma's expertise in regulatory and analytical testing accelerates product development and enables pharmaceutical companies to meet industry requirements with confidence. In addition, they can continue to use existing data collected with the syringe, as only the closure has changed, simplifying the transition process.

Available in 3, 5, and 10ml volumes, the next generation of SCHOTT TOPPAC® infuse polymer syringes are set to revolutionize the healthcare industry by providing a more efficient, stable, and sustainable solution for drug delivery.

For more, please find the original story source here.